The facility is among 12 centres established worldwide, and the first in Asia. U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech’s...
Pfizer Inc said on Tuesday it will buy migraine drug maker Biohaven Pharmaceutical Holding Company Ltd for about $11.6 billion in cash. Pfizer will acquire...
Novavax Inc on Monday revealed a sharp drop in first-quarter COVID-19 research funding and said it shipped less than a fourth of the total vaccine...
Representative image U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious...
Geneva, Even as Covid drug makers are posting record profits, the lifesaving treatments often remain out of reach for the poor, the World Health Organisation...
Chennai: Pfizer has set up a global drug development centre at the IIT Madras Research Park in Chennai, India. The centre’s capabilities will include the...
